FeBelGen gets rebrand and moves into OTC
This article was originally published in OTC Bulletin & The Rose Sheet
FeBelGen, the Belgian off-patent medicines association, has been relaunched with a new name and a broader remit under the banner of Medaxes. As well as generic and biosimilar medicines, the association will represent the OTC industry, including self-medication, self-care medical devices and food supplements.
You may also be interested in...
Supplement industry stakeholders say proposal could reveal helpful information about consumers’ regard for VMS products. But until the questions FDA will ask in interviews are known, it’s not clear whether the information collection might sow doubt about the products.
A new project devised by Pfizer and the Wellcome Trust aims to tackle antimicrobial resistance (AMR) in four sub-Saharan African countries by using real world data to track resistance patterns and allow patients to be treated more successfully. Wellcome’s Gemma Buckland-Merrett explains how the project will work and how it could help other industry partners and governments to generate valuable data in the fight against AMR.
Private equity group Carlyle has acquired 20% of Piramal’s pharma business for close to $500m, with the Indian group expected to use the capital raise to bolster organic and inorganic growth and deleverage the balance sheet.